Truist Financial analyst Nicole Germino maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today and set a price target of ...

Truist Securities adjusted its outlook for Sangamo BioSciences, reducing the price target on the company's shares to $5 from ...

Catalyst Biosciences is a step closer to challenging ... and there was new data at ISTH for both haemophilia A and B. Sangamo presented clinical results on two more patients with haemophilia ...

Scale Biosciences has not yet contributed any content. Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and ...

Now Gilead is spending a further $150 million upfront to access the cutting edge gene-editing technology of another Californian biotech, Sangamo. The ambition for this cancer-focused collaboration ...

After hours: January 23 at 6:55:15 PM EST Loading Chart for SGMT ...

After hours: January 24 at 6:21:39 PM EST Loading Chart for NBIX ...

After hours: 7:56:58 p.m. EST ...